A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)



Status:Recruiting
Conditions:Migraine Headaches
Therapuetic Areas:Neurology
Healthy:No
Age Range:17 - 80
Updated:3/15/2019
Start Date:January 18, 2017
End Date:March 24, 2021
Contact:Teva U.S. Medical Information
Email:USMedInfo@tevapharm.com
Phone:1-888-483-8279

Use our guide to learn which trials are right for you!

A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens (Intravenous/Subcutaneous and Subcutaneous) of TEV-48125 Versus Placebo for the Prevention of Epidosic Cluster Headache

This is a 13-week, multicenter, randomized, double-blind, double-dummy, placebo-controlled,
parallel-group study to compare the efficacy and safety of 2 dose regimens of TEV-48125
(Fremanezumab) versus placebo in adult patients for the prevention of ECH.


Inclusion Criteria:

- The patient has a history of ECH according to the International Classification of
Headache Disorders - 3 beta criteria (Headache Classification Committee of the IHS
2013) for ≥12 months prior to screening

- The patient has a total body weight of ≥45 kg (99 lbs.)

- The patient is in good health in the opinion of the investigator

- Women of childbearing potential (WOCBP) whose male partners are potentially fertile
(ie, no vasectomy) must use highly effective birth control methods for the duration of
the study

- Men must be sterile, or if they are potentially fertile/reproductively competent (not
surgically [eg, vasectomy] or congenitally sterile) and their female partners are of
childbearing potential, must agree to use, together with their female partners,
acceptable birth control

- If a patient is receiving Botox, it should be in a stable dose regimen, considered as
having ≥2 cycles of Botox prior to screening. The patient should not receive Botox
during the run-in period up to the evaluation period (4 weeks) where the primary
endpoint is evaluated.

- Additional criteria apply, please contact the investigator for more information

Exclusion Criteria:

- The patient has used systemic steroids for any medical reason (including treatment of
the current CH cycle within ≤7 days prior to screening The patient has used an
intervention/device (eg, scheduled nerve blocks) for headache during the 4 weeks prior
to screening.

- The patient has clinically significant hematological, renal, endocrine, immunologic,
pulmonary, gastrointestinal, genitourinary, cardiovascular, neurologic, hepatic, or
ocular disease at the discretion of the investigator.

- The patient has evidence or medical history of clinically significant psychiatric
issues determined at the discretion of the investigator.

- The patient has a past or current history of cancer or malignant tumor in the past 5
years, except for appropriately treated non-melanoma skin carcinoma.

- The patient is pregnant or lactating.

- The patient has a history of hypersensitivity reactions to injected proteins,
including monoclonal antibodies.

- The patient has participated in a clinical study of a monoclonal antibody within 3
months or 5 half-lives before administration of the first dose of the IMP, whichever
is longer, unless it is known that the patient received placebo during the study.

- The patient has a history of prior exposure to a monoclonal antibody targeting the
calcitonin gene-related peptide (CGRP) pathway (AMG 334, ALD304, LY2951742, or
fremanezumab). If patient has participated in a clinical study with any of these
monoclonal antibodies, it has to be confirmed that the patient received placebo in
order to be eligible for this study.

- The patient is an employee of the sponsor/participating study center who is directly
involved in the study or is the relative of such an employee.

- The patient has an active implant for neurostimulation used in the treatment of CH.

- The patient is a member of a vulnerable population (eg, people kept in detention).

- The patient has a history of alcohol abuse prior to screening and/or drug abuse that
in the investigator's opinion could interfere with the study evaluations or the
patient's safety .

- Additional criteria apply, please contact the investigator for more information
We found this trial at
32
sites
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
Albuquerque, New Mexico 87102
?
mi
from
Albuquerque, NM
Click here to add this to my saved trials
?
mi
from
Amherst, NY
Click here to add this to my saved trials
Ann Arbor, Michigan
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
?
mi
from
Auchenflower,
Click here to add this to my saved trials
?
mi
from
Aurora, CO
Click here to add this to my saved trials
Canoga Park, California
?
mi
from
Canoga Park, CA
Click here to add this to my saved trials
Chicago, Illinois
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Colorado Springs, Colorado
?
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
?
mi
from
Columbus, GA
Click here to add this to my saved trials
?
mi
from
Denver, CO
Click here to add this to my saved trials
Englewood, Colorado
?
mi
from
Englewood, CO
Click here to add this to my saved trials
Gainesville, Florida
?
mi
from
Gainesville, FL
Click here to add this to my saved trials
Las Vegas, Nevada
?
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Lebanon, New Hampshire
?
mi
from
Lebanon, NH
Click here to add this to my saved trials
New Haven, Connecticut
?
mi
from
New Haven, CT
Click here to add this to my saved trials
New York, New York
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
Orlando, FL
Click here to add this to my saved trials
Ormond Beach, Florida
?
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Philadelphia, Pennsylvania
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phoenix, Arizona
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Princeton, New Jersey
?
mi
from
Princeton, NJ
Click here to add this to my saved trials
Raleigh, North Carolina
?
mi
from
Raleigh, NC
Click here to add this to my saved trials
Richmond, Texas 77307
?
mi
from
Richmond, TX
Click here to add this to my saved trials
Saint Petersburg, Florida
?
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Salisbury, North Carolina
?
mi
from
Salisbury, NC
Click here to add this to my saved trials
Santa Monica, California
?
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Savannah, Georgia 31406
?
mi
from
Savannah, GA
Click here to add this to my saved trials
Stamford, Connecticut
?
mi
from
Stamford, CT
Click here to add this to my saved trials
Stanford, California
?
mi
from
Stanford, CA
Click here to add this to my saved trials
Tampa, Florida
?
mi
from
Tampa, FL
Click here to add this to my saved trials
Virginia Beach, Virginia
?
mi
from
Virginia Beach, VA
Click here to add this to my saved trials